The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
High frequency of p16INK4A gene alterations in hepatocellular carcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 1×
“The p16 gene is believed to encode a negative regulatory protein which prevents the cell cycle progression from G1 to S phase by inhibiting the catalytic activity of the CDK4 or CDK6/cyclin D complex and subsequently Rb protein phosphorylation (Serrano et al., 1993; Kamb et al., 1994).”
BackgroundA cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751 · cited 3×
“The p16 gene is believed to encode a negative regulatory protein which prevents the cell cycle progression from G1 to S phase by inhibiting the catalytic activity of the CDK4 or CDK6/cyclin D complex and subsequently Rb protein phosphorylation (Serrano et al., 1993; Kamb et al., 1994).”
BackgroundDeletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · cited 1×
“The loss of p19ARF/p16b may lead to the inactivation of the p53 functions including G1 arrest and apoptosis (Pomerantz et al., 1998; Zhang et al., 1998).”
Background
Cited by
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Hepatocellular Carcinoma: The Need for Progress
Thomas, M. B., & Zhu, A. X. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.196 · Cited by 406
Viral hepatitis and liver cancer: the case of hepatitis C
Levrero, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209562 · Cited by 404
Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis
Lee, S., Lee, H. J., Kim, J.-H., Lee, H.-S., Jang, J. J., & Kang, G. H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63495-5 · Cited by 330
Metadata
- Authors
- Liew, C. T., Li, H.-M., Lo, K.-W., Leow, C. K., Chan, J. Y., Hin, L. Y., Lau, W. Y., Lai, P. B. S., Lim, B. K., Huang, J., Leung, W. T., Wu, S., & Lee, J. C. K.
- Venue
- Oncogene
- Published
- 1999-01-21
- Volume
- 18
- Issue
- 3
- Pages
- 789-795
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2313904043
- Cited by
- 180
- References
- 5
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.